4G Clinical

Pharmaceuticals

United States, Massachusetts

$10M to $25M

201-500

Endo Aesthetics

Pharmaceuticals

United States, Michigan

$10M to $25M

201-500

GRX Holdings

Pharmaceuticals

United States, Iowa

$10M to $25M

201-500

ADH Health Products

Pharmaceuticals

United States, New York

$10M to $25M

201-500

PhRMA

Pharmaceuticals

United States, District of Columbia

$10M to $25M

201-500

Restore Health

Pharmaceuticals

United States, Wisconsin

$10M to $25M

201-500

GenRx Pharmacy

Pharmaceuticals

United States, Arizona

$10M to $25M

201-500

EPI Health, a NOVAN company

Pharmaceuticals

United States, South Carolina

$10M to $25M

201-500

Agno Pharma

Pharmaceuticals

United States, New Jersey

$10M to $25M

201-500

Pharmacy Unlimited

Pharmaceuticals

United States, Texas

$10M to $25M

201-500

Leiters Health

Pharmaceuticals

United States, Colorado

$10M to $25M

201-500

Heartland LTC Pharmacy

Pharmaceuticals

United States, Idaho

$10M to $25M

201-500

Indevus Pharmaceuticals

Pharmaceuticals

United States, Delaware

$10M to $25M

201-500

Surmasis Pharmaceutical

Pharmaceuticals

United States, Iowa

$10M to $25M

201-500

Sumitomo Pharma Oncology

Pharmaceuticals

United States, Massachusetts

$10M to $25M

201-500

Sunray Drugs Pharmacy

Pharmaceuticals

United States, Pennsylvania

$10M to $25M

201-500

BWT Pharma & Biotech

Pharmaceuticals

United States, Massachusetts

$10M to $25M

201-500

Interphil Laboratories

Pharmaceuticals

United States, California

$10M to $25M

201-500

Pileje

Pharmaceuticals

United States, Texas

$10M to $25M

201-500

OM Pharma

Pharmaceuticals

United States, Texas

$10M to $25M

201-500